Literature DB >> 2884159

Importance of glucagon in the control of futile cycling as studied in alloxan-diabetic dogs.

H L Lickley, F W Kemmer, K M el-Tayeb, M Vranic.   

Abstract

In order to determine the role of glucagon in futile or substrate cycling in diabetes, we measured tracer determined glucose kinetics during a combined infusion of 2-3H-glucose (total glucose production) and 6-3H-glucose (glucose production) in six alloxan-diabetic dogs. The animals received either a 420 min infusion of (1) somatostatin alone (0.3 microgram X kg-1 X min-1), (2) somatostatin with insulin replacement (100 microU X kg-1 X min-1) or (3) glucagon (6 ng X kg-1 X min-1) together with somatostatin and transient insulin replacement. When somatostatin was given alone, plasma glucagon (p less than 0.004) and insulin (p less than 0.0001) were suppressed. Glucose production and disappearance and plasma glucose concentrations fell (p less than 0.0001), but the metabolic clearance of glucose did not change significantly. In the basal state, futile cycling comprised 29 +/- 4%, 33 +/- 4% and 33 +/- 3% of total glucose production in the three groups of studies, which is high compared to normal dogs. The absolute rate of futile cycling fell slightly but significantly from 10.0 +/- 1.7 to 8.3 +/- 1.7 mumol X kg X -1 min-1 (p less than 0.0008). When insulin replacement was given during somatostatin infusion to correct for the small somatostatin-induced insulin suppression, there were similar changes in plasma glucagon, glucose concentrations and glucose kinetics as seen during the infusion of somatostatin alone. Futile cycling decreased to a slightly greater extent from 12.8 +/- 2.8 to 9.5 +/- 1.7 mumol X kg-1 X min.-1 (p less than 0.02).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2884159     DOI: 10.1007/bf00274224

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  35 in total

Review 1.  Substrate cycles in metabolic regulation and in heat generation.

Authors:  E A Newsholme; B Crabtree
Journal:  Biochem Soc Symp       Date:  1976

2.  Coated charcoal immunoassay of insulin.

Authors:  V Herbert; K S Lau; C W Gottlieb; S J Bleicher
Journal:  J Clin Endocrinol Metab       Date:  1965-10       Impact factor: 5.958

Review 3.  The metabolic clearance of glucose: measurement and meaning.

Authors:  J Radziuk; H L Lickley
Journal:  Diabetologia       Date:  1985-06       Impact factor: 10.122

Review 4.  The Banting Memorial Lecture 1975. Diabetes and the alpha cell.

Authors:  R H Unger
Journal:  Diabetes       Date:  1976-02       Impact factor: 9.461

5.  Experimental validation of measurements of glucose turnover in nonsteady state.

Authors:  J Radziuk; K H Norwich; M Vranic
Journal:  Am J Physiol       Date:  1978-01

6.  Extrapancreatic effect of somatostatin infusion to increase glucose clearance.

Authors:  R N Bergman; M Ader; D T Finegood; G Pacini
Journal:  Am J Physiol       Date:  1984-09

7.  Increased glucose turnover and glucose cycling in acromegalic patients with normal glucose tolerance.

Authors:  S Karlander; M Vranić; S Efendić
Journal:  Diabetologia       Date:  1986-11       Impact factor: 10.122

8.  Increased activity of the glucose cycle in the liver: early characteristic of type 2 diabetes.

Authors:  S Efendić; A Wajngot; M Vranić
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

9.  Evidence for suppression of hepatic glucose-6-phosphatase with carbohydrate feeding.

Authors:  C B Newgard; D W Foster; J D McGarry
Journal:  Diabetes       Date:  1984-02       Impact factor: 9.461

10.  Importance of glucagon in mediating epinephrine-induced hyperglycemia in alloxan-diabetic dogs.

Authors:  G Perez; F W Kemmer; H L Lickley; M Vranic
Journal:  Am J Physiol       Date:  1981-10
View more
  3 in total

1.  Failure of glucagon suppression contributes to postprandial hyperglycaemia in IDDM.

Authors:  S Dinneen; A Alzaid; D Turk; R Rizza
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

2.  Contribution of glucose/glucose 6-phosphate cycle activity to insulin resistance in type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  D P Rooney; R D Neely; O Beatty; N P Bell; B Sheridan; A B Atkinson; E R Trimble; P M Bell
Journal:  Diabetologia       Date:  1993-02       Impact factor: 10.122

3.  Mild type II diabetes markedly increases glucose cycling in the postabsorptive state and during glucose infusion irrespective of obesity.

Authors:  S Efendic; S Karlander; M Vranic
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.